StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Zivo Bioscience's pe ratio was 79.4× on Apr 30, 2015.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Apr 30, 201579.4×−206.6
2014Dec 31, 2014286.0×–

More Zivo Bioscience figures

See a number that looks wrong?